by John A. Jenkins | Jan 8, 2026 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: Growing Scrutiny of Drug Safety and Enforcement As GLP-1 weight-loss drugs surge in popularity, major news organizations are pressing the Food and Drug Administration for internal records that reveal what regulators knew about reports of dangers...
by John A. Jenkins | Dec 10, 2025 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: The Investigative Outlet Gets Active at the FDA Capitol Forum may be one of the more under-the-radar journalistic enterprises in Washington, but recently it was easily the most active when it came to filing FOIA requests with the Food and Drug...
by John A. Jenkins | Dec 3, 2025 | FOIA, Short-Selling, Stock Market
FOIAengine: “Cassandra Unchained” Plays to Fear and Greed Michael Burry, the reclusive contrarian who foresaw the 2007 subprime collapse and became the reluctant hero of The Big Short, has walked away from professional money management for the second — and perhaps...
by John A. Jenkins | Nov 12, 2025 | FOIA, SEC
FOIAengine: SEC’s$2.5 Billion Outsourcing Contract Explained The Securities and Exchange Commission, which signed a staffing contract potentially worth $2.5 billion with a Texas-based Alaska Native corporation, appears to have relied heavily on the outside contractor...
by John A. Jenkins | Nov 5, 2025 | Antitrust, Cryptocurrency, FOIA, FTC, Politics, SEC
FOIAengine: Tort Lawyers, Watchdogs Continue the Fight The October 21 presidential pardon that wiped away Changpeng Zhao’s criminal history may have erased the felony conviction of the Binance founder, but it hasn’t freed his empire – or quieted the controversy. ...
